NCT05788276View on ClinicalTrials.gov

Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?

PHASE4RecruitingINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

May 2, 2023

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Kidney Transplant; ComplicationsKidney Transplant FailureRenal Failure
Interventions
DRUG

Dapagliflozin 10mg Tab

Dapagliflozin active tablets

DRUG

Placebo

Matched placebo tablets

Trial Locations (1)

0372

RECRUITING

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

collaborator

University Hospital of North Norway

OTHER

collaborator

Haukeland University Hospital

OTHER

lead

Oslo University Hospital

OTHER